- Home
- GOVX
GOVX
GeoVax Labs Inc.
as 04-25-2025 4:00pm EST
| Founded: | 2001 | Country: | United States |
| Employees: | N/A | City: | SMYRNA |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $13.40 | AVG Volume (30 days): | 516.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.73 - $11.18 | Next Earning Date: | 05-13-2025 |
| Revenue: | $3,954,576 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 99.47% | Revenue Growth (next year): | -18.53% |
Latest GeoVax Labs Inc. News
GOVX Breaking Stock News: Dive into GOVX Ticker-Specific Updates for Smart Investing
NewMediaWire
a day ago
GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater
NewMediaWire
2 days ago
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress
NewMediaWire
3 days ago
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
NewMediaWire
4 days ago
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
NewMediaWire
9 days ago
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
TipRanks
10 days ago
GeoVax Labs price target lowered to $14 from $18 at D. Boral Capital
NewMediaWire
10 days ago
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum
MT Newswires
10 days ago
Sector Update: Health Care Stocks Retreat Late Afternoon
Compare GOVX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GOVX GeoVax Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.